Difficulty: Medium
Average Score: 70%
Practice
A child ady in a clinical risk group who has never received any influenza vaccine before should have:
Correct answer
D
Rationale
In this scenario, the correct answer is option D, which states that the child should receive two doses of LAIV at least 4 weeks apart. This recommendation aligns with the current guidelines for influenza vaccination in children in clinical risk groups.
The rationale behind this recommendation is that children who have never received any influenza vaccine before and are considered at high risk for complications from influenza should receive two doses of LAIV to ensure adequate protection. The two doses are necessary to stimulate a robust immune response in these vulnerable individuals.
Options A and B are incorrect because they suggest a mix of inactivated and live attenuated influenza vaccines in a sequence that is not supported by current guidelines. Mixing different types of influenza vaccines in this manner is not recommended due to potential interference with the immune response.
Option C is also incorrect as it suggests only one dose of LAIV, which may not provide sufficient protection, especially for a child in a clinical risk group.
This question is important in an educational context as it highlights the specific vaccination recommendations for children at high risk for influenza complications. Understanding these guidelines is crucial for healthcare professionals to ensure appropriate vaccination practices and protect vulnerable populations from preventable diseases.
The rationale behind this recommendation is that children who have never received any influenza vaccine before and are considered at high risk for complications from influenza should receive two doses of LAIV to ensure adequate protection. The two doses are necessary to stimulate a robust immune response in these vulnerable individuals.
Options A and B are incorrect because they suggest a mix of inactivated and live attenuated influenza vaccines in a sequence that is not supported by current guidelines. Mixing different types of influenza vaccines in this manner is not recommended due to potential interference with the immune response.
Option C is also incorrect as it suggests only one dose of LAIV, which may not provide sufficient protection, especially for a child in a clinical risk group.
This question is important in an educational context as it highlights the specific vaccination recommendations for children at high risk for influenza complications. Understanding these guidelines is crucial for healthcare professionals to ensure appropriate vaccination practices and protect vulnerable populations from preventable diseases.